Blurbs

Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Anthem (ANTM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Insmed (INSMResearch Report), Anthem (ANTMResearch Report) and Decibel Therapeutics (DBTXResearch Report) with bullish sentiments.

Insmed (INSM)

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Insmed, with a price target of $55.00. The company’s shares closed last Wednesday at $25.03.

According to TipRanks.com, Bayko is a 4-star analyst with an average return of 7.2% and a 42.0% success rate. Bayko covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Madrigal Pharmaceuticals, and Kiniksa Pharmaceuticals.

Insmed has an analyst consensus of Strong Buy, with a price target consensus of $48.80.

See Insiders’ Hot Stocks on TipRanks >>

Anthem (ANTM)

Evercore ISI analyst Michael Newshel maintained a Buy rating on Anthem yesterday and set a price target of $335.00. The company’s shares closed last Wednesday at $529.84.

Newshel has an average return of 25.3% when recommending Anthem.

According to TipRanks.com, Newshel is ranked #2444 out of 7938 analysts.

Currently, the analyst consensus on Anthem is a Strong Buy with an average price target of $501.38, representing a -4.0% downside. In a report issued on April 6, Jefferies also maintained a Buy rating on the stock with a $575.00 price target.

Decibel Therapeutics (DBTX)

In a report issued on April 19, Jack Allen from Robert W. Baird maintained a Buy rating on Decibel Therapeutics, with a price target of $21.00. The company’s shares closed last Wednesday at $2.34, close to its 52-week low of $2.00.

According to TipRanks.com, Allen has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -24.0% and a 18.2% success rate. Allen covers the Healthcare sector, focusing on stocks such as Intellia Therapeutics, Taysha Gene Therapies, and Voyager Therapeutics.

Decibel Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $16.25.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on INSM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos